The Exchange had sought clarification from Archean Chemical Industries Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archean Chemical Industries clarified to NSE that the word 'unaudited' appearing in the balance sheet of its Q4 FY25 results was an inadvertent typographical error — the results were actually audited as per SEBI's Regulation 33 format. The company also acknowledged that it had missed uploading the Machine-Readable Form of the financial results and has now submitted it. The filing is a routine compliance clarification with no impact on the underlying numbers. The audited results show standalone FY25 revenue from operations of Rs. 1,01,379.02 lakhs and profit after tax of Rs. 18,492.34 lakhs (down from Rs. 32,234.56 lakhs in FY24), with basic EPS of Rs. 14.98. The board has recommended a final dividend of Rs. 1.50 per share (75%) for FY25. The company also flagged strategic investments in Clas-SiC Wafer Fab (UK) and Offgrid Energy Labs (US), and the consolidation of Oren Hydrocarbons (now Idealis Mudchemie) as a step-down subsidiary.
This is a procedural clarification with no financial or governance impact — shareholders can rely on the original audited numbers. The dip in FY25 profitability versus FY24 is worth noting, but is unrelated to this filing.